GHS-R1a

What Is Ipamorelin? The Ghrelin-Receptor Peptide, Its One Human Trial, and Its Canadian Status

Ipamorelin is filed beside sermorelin and tesamorelin as though all three did the same thing. It acts at a different receptor, its one published efficacy trial missed its endpoint, and Health Canada named it in April 2026 among unauthorized injectable peptides.